FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Equine Vet J / Equine botulism.
Equine veterinary journal2025; doi: 10.1111/evj.14542

Equine botulism.

Abstract: Botulism is a severe and often fatal disease in equine patients worldwide. Clostridium botulinum is a ubiquitous soil organism which produces a potent neurotoxin resulting in neuromuscular blockade and flaccid paralysis in affected animals. Definitive diagnosis is often impractical or impossible, leading to diagnosis and treatment based on clinical experience and presenting signs. Delay in case identification and treatment results in rapid deterioration of the patient. Treatment of recumbent equine botulism cases presents challenges due to patient size and requires intensive nursing care. This review summarises the current knowledge on equine botulism, including pathophysiology, clinical presentations, diagnostic and treatment options and prevention.
© 2025 The Author(s). Equine Veterinary Journal published by John Wiley & Sons Ltd on behalf of EVJ Ltd.
Get Full Text
Publication Date: 2025-06-15 PubMed ID: 40518698DOI: 10.1111/evj.14542Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The article provides a comprehensive review of the disease known as equine botulism, summarizing current knowledge on its pathophysiology, clinical presentations, diagnostic and treatment options, as well as preventive measures.

Pathophysiology of Equine Botulism

  • The research delves into botulism as it affects horses, explaining the pathophysiology or functional changes that accompany the disease.
  • It identifies the disease as severe and potentially fatal to equine species around the globe.
  • The disease, caused by the Clostridium botulinum, a widespread soil organism, produces a powerful neurotoxin which causes a neuromuscular blockade resulting in a limp paralysis in affected horses.

Clinical Presentation and Diagnosis

  • The authors discuss the clinical signs or symptoms upon which a presumptive diagnosis of botulism can be based.
  • They acknowledge that a definitive diagnosis, which would require more advanced testing, is often unrealizable or impracticable, leading to diagnoses based mainly on observed clinical signs and medical experience.
  • One key point made in the article is the swift deterioration of the patient’s health if the identification and management of the pathology is delayed.

Treatment and Care

  • The study underscores the difficulties in handling and offering care to equine botulism patients due to their large size.
  • These patients often need intensive nursing care, and the authors highlight the challenges of providing such care and the need for efficient and effective treatments.

Disease Prevention

  • The researchers also touch on preventive measures to curb the spread and incidence of this disease among equine patients.
  • Prevention strategies, while important, were not detailed in the abstract, likely being covered extensively in the full body of the paper.

This abstract serves as a concise summary of the broader topic and prompts an array of further questions, encouraging a more comprehensive exploration in the actual article.

Cite This Article

APA
Slavik K, Whitlock R, Johnson A. (2025). Equine botulism. Equine Vet J. https://doi.org/10.1111/evj.14542

Publication

Equine veterinary journal
ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English

Researcher Affiliations

Slavik, Kali
  • Department of Clinical Studies-New Bolton, School of Veterinary Medicine, University of Pennsylvania, Kennett Square, Pennsylvania, USA.
Whitlock, Robert
  • Department of Clinical Studies-New Bolton, School of Veterinary Medicine, University of Pennsylvania, Kennett Square, Pennsylvania, USA.
Johnson, Amy
  • Department of Clinical Studies-New Bolton, School of Veterinary Medicine, University of Pennsylvania, Kennett Square, Pennsylvania, USA.

References

This article includes 113 references
  1. Galey FD. Botulism in the horse.. Vet Clin North Am Equine Pract 2001;17(3):579–588.
  2. Stratford CH, Mayhew IG, Hudson NPH. Equine botulism: a clinical approach to diagnosis and management.. Equine Vet Educ 2014;26(8):441–448.
  3. Aureli P. Botulism.. In: Quah SR, editor. International encyclopedia of public health. Amsterdam, The Netherlands: Academic Press, Elsevier; 2017. p. 254–262.
  4. Fach P, Gibert M, Griffais R, Popoff MR. Investigation of animal botulism outbreaks by PCR and standard methods.. FEMS Immunol Med Microbiol 1996;13(4):279–285.
  5. Swink JM, Gilsenan WF. Clostridial diseases (botulism and tetanus).. Vet Clin North Am Equine Pract 2022;38(2):269–282.
  6. Cai S, Singh BR, Sharma S. Botulism diagnostics: from clinical symptoms to in vitro assays.. Crit Rev Microbiol 2007;33(2):109–125.
  7. Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS. Botulinum toxin as a biological weapon.. Jama 2001;285(8):1059.
  8. Horowitz BZ. Botulinum toxin.. Crit Care Clin 2005;21(4):825–839. viii.
  9. Rossetto O, Montecucco C. Tables of toxicity of botulinum and tetanus neurotoxins.. Toxins (Basel) 2019;11(12):686.
  10. Carbrey JM, Song L, Zhou Y, Yoshinaga M, Rojek A, Wang Y. Reduced arsenic clearance and increased toxicity in aquaglyceroporin‐9‐null mice.. Proc Natl Acad Sci U S A 2009;106(37):15956–15960.
  11. Whitlock RH, Buckley C. Botulism.. Vet Clin North Am Equine Pract 1997;13(1):107–128.
  12. Kinde H, Bettey RL, Ardans A, Galey FD, Daft BM, Walker RL. Clostridium botulinum type‐C intoxication associated with consumption of processed alfalfa hay cubes in horses.. J Am Vet Med Assoc 1991;199(6):742–746.
  13. Allison MJ, Maloy SE, Matson RR. Inactivation of Clostridium botulinum toxin by ruminal microbes from cattle and sheep.. Appl Environ Microbiol 1976;32(5):685–688.
  14. Critchley EM. A comparison of human and animal botulism: a review.. J R Soc Med 1991;84(5):295–298.
  15. Gerber V, Straub R, Frey J. Equine botulism and acute pasture myodystrophy: new soil‐borne emerging diseases in Switzerland?. Schweiz Arch Tierheilkd 2006;148(10):553–559.
  16. Johnson AL, McAdams SC, Whitlock RH. Type A botulism in horses in the United States: a review of the past ten years (1998–2008).. J Vet Diagn Invest 2010;22(2):165–173.
  17. Le Bouquin S, Lucas C, Souillard R, Le Marechal C, Petit K, Koch P. Human and animal botulism surveillance in France from 2008 to 2019.. Front Public Health 2022;10:21–32.
  18. Whitlock RH. Botulism, type C: experimental and field cases in horses.. Equine Pract 1996;18(10):11–17.
  19. Uriarte A, Thibaud JL, Blot S. Botulism in 2 urban dogs.. Can Vet J 2010;51(10):1139–1142.
  20. Jeyaraja K, Saikrishna KS, Kumar EV, Ramprabhu R. Botulism in dogs: a clinical case study.. J Entomol Zool Stud 2021;9(3):346–347.
  21. Brunt J, Carter AT, Stringer SC, Peck MW. Identification of a novel botulinum neurotoxin gene cluster in Enterococcus.. FEBS Lett 2018;592(3):310–317.
  22. Brunt J, van Vliet AHM, Carter AT, Stringer SC, Amar C, Grant KA. Diversity of the genomes and neurotoxins of strains of Clostridium botulinum Group I and Clostridium sporogenes associated with foodborne, infant and wound botulism.. Toxins (Basel) 2020;12(9):586.
  23. Hackett G, Moore K, Burgin D, Hornby F, Gray B, Elliott M. Purification and characterization of recombinant botulinum neurotoxin serotype FA, also known as serotype H.. Toxins (Basel) 2018;10(5):195.
  24. Zhang S, Lebreton F, Mansfield MJ, Miyashita SI, Zhang J, Schwartzman JA. Identification of a botulinum neurotoxin‐like toxin in a commensal strain of enterococcus faecium.. Cell Host Microbe 2018;23(2):169–176. e6.
  25. Zhang S, Masuyer G, Zhang J, Shen Y, Lundin D, Henriksson L. Identification and characterization of a novel botulinum neurotoxin.. Nat Commun 2017;8:14130.
  26. Frey J, Eberle S, Stahl C, Mazuet C, Popoff M, Schatzmann E. Alternative vaccination against equine botulism (BoNT/C).. Equine Vet J 2007;39(6):516–520.
  27. Shnaiderman‐Torban A, Elad D, Kelmer G, Avni G, Shalit U, Steinman A. An outbreak of equine botulism type D in Israel.. Equine Vet Educ 2018;30(11):594–597.
  28. Taylor SD, Toth B, Townsend WM, Bentley RT. Mechanical ventilation and management of an adult horse with presumptive botulism.. J Vet Emerg Crit Care (San Antonio) 2014;24(5):594–601.
  29. Schoenbaum MA, Hall SM, Glock RD, Grant K, Jenny AL, Schiefer TJ. An outbreak of type C botulism in 12 horses and a mule.. J Am Vet Med Assoc 2000;217(3):365–368. 340.
  30. Bernard W, Divers TJ, Whitlock RH, Messick J, Tulleners E. Botulism as a sequel to open castration in a horse.. J Am Vet Med Assoc 1987;191(1):73–74.
  31. Johnson AL, McAdams‐Gallagher SC, Sweeney RW. Quantitative real‐time PCR for detection of neurotoxin genes of Clostridium botulinum types A, B and C in equine samples.. Vet J 2014;199(1):157–161.
  32. French NP, McCarthy HE, Diggle PJ, Proudman CJ. Clustering of equine grass sickness cases in the United Kingdom: a study considering the effect of position‐dependent reporting on the space–time K‐function.. Epidemiol Infect 2005;133(2):343–348.
  33. Kasap S, Batmaz H, Kocatürk M, Gessler F, Catık S, Topal O. Botulism (type A) in a horse—case report.. Acta Veterinaria Brno 2016;85(1):71–76.
  34. Ricketts SW, Greet TRC, Glyn PJ, Ginnett CDR, McAllister EP, McCAIG J. Thirteen cases of botulism in horses fed big bale silage.. Equine Vet J 1984;16(6):515–518.
  35. Fung HT, Chan KM, Lam SKT. A review on iatrogenic botulism.. Hong Kong J Emerg Med 2020;27(6):356–367.
  36. Adam‐Castrillo D, White NA II, Donaldson LL, Furr MO. Effects of injection of botulinum toxin type B into the external anal sphincter on anal pressure of horses.. Am J Vet Res 2004;65(1):26–30.
  37. Bonventre PF. Absorption of botulinal toxin from the gastrointestinal tract.. Clin Infect Dis 1979;1(4):663–667.
  38. Matsumura T, Sugawara Y, Yutani M, Amatsu S, Yagita H, Kohda T. Botulinum toxin A complex exploits intestinal M cells to enter the host and exert neurotoxicity.. Nat Commun 2015;6(1):6255.
  39. Ostrowski SR, Kubiski SV, Palmero J, Reilly CM, Higgins JK, Cook‐Cronin S. An outbreak of equine botulism type A associated with feeding grass clippings.. J Vet Diagn Invest 2012;24(3):601–603.
  40. Semrad S, Peek S. Case notes and commentary: equine botulism.. Compend Contin Educ Pract Vet 2002;24(2):169–172.
  41. Swerczek TW. Toxicoinfectious botulism in foals and adult horses.. J Am Vet Med Assoc 1980;176(3):217–220.
  42. Whitlock RH, McAdams S. Equine botulism.. Clin Tech Equine Pract 2006;5(1):37–42.
  43. McCarthy HE, French NP, Edwards GB, Poxton IR, Kelly DF, Payne‐Johnson CE. Equine grass sickness is associated with low antibody levels to Clostridium botulinum: a matched case–control study.. Equine Vet J 2004;36(2):123–129.
  44. McGorum BC, Chen Z, Glendinning L, Gweon HS, Hunt L, Ivens A. Equine grass sickness (a multiple systems neuropathy) is associated with alterations in the gastrointestinal mycobiome.. Anim Microbiome 2021;3(1):70.
  45. McGorum BC, Davey T, Dosi MCM, Keen JA, Morrison LR, Pirie RS. Equine grass sickness is associated with major abnormalities in the ultrastructure of skeletal neuromuscular junctions.. Equine Vet J 2025;57(1):193–202.
  46. Mitten LA, Hinchcliff KW, Holcombe SJ, Reed SM. Mechanical ventilation and management of botulism secondary to an injection abscess in an adult horse.. Equine Vet J 1994;26(5):420–423.
  47. Wijnberg ID, Schrama SEA, Elgersma AE, Maree JTM, de Cocq P, Back W. Quantification of surface EMG signals to monitor the effect of a Botox treatment in six healthy ponies and two horses with stringhalt: preliminary study.. Equine Vet J 2009;41(3):313–318.
  48. Hardeman LC, van der Meij BR, Oosterlinck M, Veraa S, van der Kolk JH, Wijnberg ID. Effect of Clostridium botulinum toxin type A injections into the deep digital flexor muscle on the range of motion of the metacarpus and carpus, and the force distribution underneath the hooves, of sound horses at the walk.. Vet J 2013;198:e152–e156.
  49. Hardeman LC, van der Meij BR, Back W, van der Kolk JH, Winjberg ID. The use of electromyography interference pattern analysis to determine muscle force of the deep digital flexor muscle in healthy and laminitic horses.. Vet Q 2016;36(1):10–15.
  50. Wijnberg ID, Hardeman LC, van der Meij BR, Veraa S, Back W, van der Kolk JH. The effect of Clostridium botulinum toxin type A injections on motor unit activity of the deep digital flexor muscle in healthy sound Royal Dutch sport horses.. Vet J 2013;198(Suppl 1):e147–e151.
  51. Gutierrez‐Nibeyro SD, Santos MP, White NA, Brown JA, Adams MN, McKnight AL. Effects of intrabursal administration of botulinum toxin type B on lameness in horses with degenerative injury to the podotrochlear apparatus.. Am J Vet Res 2014;75(3):282–289.
  52. Beck AAJ, Beck AA, Paz LB, Frank MI, Engelmann AM, Krause A. Safety and synovial inflammatory response after intra‐articular injection of botulinum toxin type a in healthy horses.. J Equine Vet Sci 2022;110:103865.
  53. Turin L, Piccione MM, Crosa F, Dall'Ara P, Filipe J, Zarucco L. Therapeutic applications of botulinum neurotoxins in veterinary medicine.. Vet Sci 2023;10(7):460.
  54. Hunter JM, Rohrbach BW, Andrews FM, Whitlock RH. Case presentation: round bale grass hay: a risk factor for botulism in horses.. Compend Contin Educ Pract Vet 2002;24(2):166–169.
  55. Rao AK, Sobel J, Chatham‐Stephens K, Luquez C. Clinical guidelines for diagnosis and treatment of botulism, 2021.. MMWR Recomm Rep 2021;70(2):1–30.
  56. Johnson AL, McAdams‐Gallagher SC, Aceto H. Outcome of adult horses with botulism treated at a veterinary hospital: 92 cases (1989–2013).. J Vet Intern Med 2015;29(1):311–319.
  57. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome.. Brain Res 1997;745(1–2):32–36.
  58. Poulain B, Lemichez E, Popoff MR. Neuronal selectivity of botulinum neurotoxins.. Toxicon 2020;178:20–32.
  59. Wilkins PA, Palmer JE. Mechanical ventilation in foals with botulism: 9 cases (1989–2002).. J Vet Intern Med 2003;17(5):708–712.
  60. Tanahashi Y, Kitazawa T, Unno T. Muscarinic regulation of gastrointestinal motility.. New York, NY: Springer US; 2024. p. 307–340.
  61. Wilkins PA, Palmer JE. Botulism in foals less than 6 months of age: 30 cases (1989–2002).. J Vet Intern Med 2003;17(5):702–707.
  62. Kelly AP, Jones RT, Gillick JC, Sims LD. Outbreak of botulism in horses.. Equine Vet J 1984;16(6):519–521.
  63. FDA cautions horse owners not to feed recalled lots of top of the Rockies alfalfa cubes due to reports of illness and death. 2023 [cited 2023 Dec 14]. Available from: https://www.fda.gov/animal‐veterinary/outbreaks‐and‐advisories/fda‐cautions‐horse‐owners‐not‐feed‐recalled‐lots‐top‐rockies‐alfalfa‐cubes‐due‐reports‐illness‐and
  64. Dorner MB, Wilking H, Skiba M, Wilk L, Steinberg M, Worbs S. A large travel‐associated outbreak of iatrogenic botulism in four European countries following intragastric botulinum neurotoxin injections for weight reduction, Turkiye, February to March 2023.. Euro Surveill 2023;28(23):2300203.
  65. Boccagni C, Prestandrea C, D'Agostino T, Rubino F, Renda M, Sesti E. Neurophysiological patterns of acute and post‐acute foodborne botulism.. Muscle Nerve 2021;64(4):435–444.
  66. Hatheway CL. Botulism: the present status of the disease.. Heidelberg: Springer; 1995. p. 55–75.
  67. Hatheway CL. Toxigenic clostridia.. Clin Microbiol Rev 1990;3(1):66–98.
  68. Lindstrom M, Korkeala H. Laboratory diagnostics of botulism.. Clin Microbiol Rev 2006;19(2):298–314.
  69. Thirunavukkarasu N, Johnson E, Pillai S, Hodge D, Stanker L, Wentz T. Botulinum neurotoxin detection methods for public health response and surveillance.. Front Bioeng Biotechnol 2018;6.
  70. Johnson AL, McAdams‐Gallagher SC, Aceto H. Accuracy of a mouse bioassay for the diagnosis of botulism in horses.. J Vet Intern Med 2016;30(4):1293–1299.
  71. Wilder‐Kofie TD, Lúquez C, Adler M, Dykes JK, Coleman JD, Maslanka SE. An alternative in vivo method to refine the mouse bioassay for botulinum toxin detection.. Comp Med 2011;61(3):235–242.
  72. Broide RS, Rubino J, Nicholson GS, Ardila MC, Brown MS, Aoki KR. The rat digit abduction score (DAS) assay: a physiological model for assessing botulinum neurotoxin‐induced skeletal muscle paralysis.. Toxicon 2013;71:18–24.
  73. Centurioni DA, Egan CT, Perry MJ. Current developments in diagnostic assays for laboratory confirmation and investigation of botulism.. J Clin Microbiol 2022;60(4):e0013920.
  74. Cornet S, Perier C, Kalinichev M. Optimization of the rat digit abduction score (DAS) assay: evaluation of botulinum neurotoxin activity in the gastrocnemius lateralis, peronei, and extensor digitorum longus.. Toxicon X 2020;6:100029.
  75. Maslanka SE, Luquez C, Raphael BH, Dykes JK, Joseph LA. Utility of botulinum toxin ELISA A, B, E, F kits for clinical laboratory investigations of human botulism.. Botulinum J 2011;2(1):72.
  76. Masters AM, Palmer DG. Diagnosis of botulism in mammals aided by toxin ELISA and C and D gene RT‐PCRs with an emphasis on farm animals.. Vet Res Commun 2024;48(6):3803–3812.
  77. Masters AM, Palmer DG. Confirmation of botulism diagnosis in Australian bird samples by ELISA and RT rtPCR.. J Vet Diagn Invest 2021;33(4):684–694.
  78. Cheng LW, Stanker LH. Detection of botulinum neurotoxin serotypes A and B using a chemiluminescent versus electrochemiluminescent immunoassay in food and serum.. J Agric Food Chem 2013;61(3):755–760.
  79. Liu J, Gao S, Kang L, Ji B, Xin W, Kang J. An ultrasensitive gold nanoparticle‐based lateral flow test for the detection of active botulinum neurotoxin type A.. Nanoscale Res Lett 2017;12(1):227.
  80. Davis SW, Kelly‐Cirino CD, Cirino NM, Hannett GE, Musser KA, Egan C. A 10 year analysis of the use of multiplex real‐time PCR screening for botulinum neurotoxin‐producing Clostridium species.. J Bacteriol Mycol 2016;3(3):1030.
  81. Johnson AL, Sweeney RW, McAdams SC, Whitlock RH. Quantitative real‐time PCR for detection of the neurotoxin gene of Clostridium botulinum type B in equine and bovine samples.. Vet J 2012;194(1):118–120.
  82. Szabo EA, Pemberton JM, Gibson AM, Thomas RJ, Pascoe RR, Desmarchelier PM. Application of PCR to a clinical and environmental investigation of a case of equine botulism.. J Clin Microbiol 1994;32(8):1986–1991.
  83. Prutton JSW, Magdesian KG, Plummer A, Williams DC, Aleman M. Survival of a foal with type A botulism.. J Vet Intern Med 2016;30(2):675–678.
  84. Wang C, Xiao R, Wang S, Yang X, Bai Z, Li X. Magnetic quantum dot based lateral flow assay biosensor for multiplex and sensitive detection of protein toxins in food samples.. Biosens Bioelectron 2019;146:111754.
  85. Kalb S, Baudys J, Wang D, Barr J. Recommended mass spectrometry‐based strategies to identify botulinum neurotoxin‐containing samples.. Toxins 2015;7(5):1765–1778.
  86. Sharma A, Ponmariappan S, Rani S, Alam SI, Shukla S. Immunoproteomic analysis of Clostridium botulinum type B secretome for identification of immunogenic proteins against botulism.. Biotechnol Lett 2021;43(5):1019–1036.
  87. Wang D, Baudys J, Rees J, Marshall KM, Kalb SR, Parks BA. Subtyping botulinum neurotoxins by sequential multiple Endoproteases in‐gel digestion coupled with mass spectrometry.. Anal Chem 2012;84(11):4652–4658.
  88. Skinner GE, Gendel SM, Fingerhut GA, Solomon HA, Ulaszek J. Differentiation between types and strains of Clostridium botulinum by riboprinting.. J Food Prot 2000;63(10):1347–1352.
  89. Rasetti‐Escargueil C, Lemichez E, Popoff MR. Toxemia in human naturally acquired botulism.. Toxins 2020;12(11):716.
  90. Sarita R, Ponmariappan S, Sharma A, Kamboj DV, Jain AK. Development of immunodetection system for botulinum neurotoxin serotype E.. Indian J Med Res 2018;147(6):603–610.
  91. Ruby RE, Janes JG. Pathologic conditions of the nervous system in horses.. Vet Clin N Am Equine Pract 2022;38(2):427–443.
  92. Devers KG, Nine JS. Autopsy findings in botulinum toxin poisoning.. J Forensic Sci 2010;55(6):1649–1651.
  93. Wilkins PA, Palmer JE. Botulism in foals: a survivable disease.. Proceedings of the annual convention of the AAEP. Lexington, KY: American Association of Equine Practitioners; 2002.
  94. PlasVacc. EquiPlas B. 2024 [cited 2024 Dec 22]. Available from: https://plasvacc.com/wp‐content/uploads/2022/06/PV‐USA‐Product‐Sheet‐Equiplas‐B.pdf
  95. Veterinary Biological Products Licensees and Permittees Prepared February 2, 2023, U. APHIS, Editor. 2023.
  96. Lake Immunogenics. Antigen select: botulism A, B, & C toxins. 2024 [cited 2024 Dec 22]. Available from: https://www.lakeimmunogenics.com/index.php/product/antigen-select-botulism-a-b-c-toxins/
  97. Emergent BioSolutions Canada Inc. BAT (R). 2020 [cited 2025 Mar 30]. Available from: https://www.emergentbiosolutions.com/wp-content/uploads/2022/01/BAT-Canada-Monograph-English.pdf
  98. McNutt PM, Vazquez‐Cintron EJ, Tenezaca L, Ondeck CA, Kelly KE, Mangkhalakhili M. Neuronal delivery of antibodies has therapeutic effects in animal models of botulism.. Sci Transl Med 2021;13(575):eabd7789.
  99. Vazquez‐Cintron E, Machamer J, Ondeck C, Pagarigan K, Winner B, Bodner P. Symptomatic treatment of botulism with a clinically approved small molecule.. JCI Insight 2020;5(2):e132891.
  100. Cope RB. Botulinum neurotoxins.. London, UK: Elsevier; 2018. p. 743–757.
  101. Gomez D, Toribio R, Caddey B, Costa M, Vijan S, Dembek K. Longitudinal effects of oral administration of antimicrobial drugs on fecal microbiota of horses.. J Vet Intern Med 2023;37(6):2562–2572.
  102. Kinoshita Y, Niwa H, Uchida‐Fujii E, Nukada T, Ueno T. Simultaneous daily fecal microbiota transplantation fails to prevent metronidazole‐induced dysbiosis of equine gut microbiota.. J Equine Vet Sci 2022;114:104004.
  103. Wang Y, Sugiyama H. Botulism in metronidazole‐treated conventional adult mice challenged orogastrically with spores of Clostridium botulinum type A or B.. Infect Immun 1984;46(3):715–719.
  104. Dehler M, Zessin E, Bärtsch P, Mairbäurl H. Hypoxia causes permeability oedema in the constant‐pressure perfused rat lung.. Eur Respir J 2006;27(3):600–606.
  105. Sweeney RW, Hansen TO. Use of a liquid diet as the sole source of nutrition in six dysphagic horses and as a dietary supplement in seven hypophagic horses.. J Am Vet Med Assoc 1990;197(8):1030–1032.
  106. Lonati D, Schicchi A, Crevani M, Buscaglia E, Scaravaggi G, Maida F. Foodborne botulism: clinical diagnosis and medical treatment.. Toxins 2020;12(8):509.
  107. Cox N, Hinkle R. Infant botulism.. Am Fam Physician 2002;65(7):1388–1392.
  108. Guru PK, Becker TL, Stephens A, Cannistraro RJ, Eidelman BH, Hata DJ. Adult intestinal botulism: a rare presentation in an immunocompromised patient with short bowel syndrome.. Mayo Clin Proc Innov Qual Outcomes 2018;2(3):291–296.
  109. Han J, Park HY, Shin HJ, Chung SH, do SH. Effects of magnesium sulphate on neostigmine‐induced recovery from moderate neuromuscular blockade with rocuronium: a randomized controlled trial.. Magnes Res 2023;36(2):31–39.
  110. Botulism vaccination guidelines. 2019 [cited 2024 Jul 5]. Available from: https://aaep.org/resource/botulism-vaccination-guidelines/
  111. Cohen ND, Bordin AI. Principles of vaccination.. In: Equine Clinical Immunology. Chichester, UK: John Wiley & Sons, Inc.; 2015. p. 263–278.
  112. Ryan C, Giguère S. Equine neonates have attenuated humoral and cell‐mediated immune responses to a killed adjuvanted vaccine compared to adult horses.. Clin Vaccine Immunol 2010;17(12):1896–1902.
  113. Stahl C, Unger L, Mazuet C, Popoff M, Straub R, Frey J. Immune response of horses to vaccination with the recombinant Hc domain of botulinum neurotoxin types C and D.. Vaccine 2009;27(41):5661–5666.

Citations

This article has been cited 0 times.
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.